OxyContin

DRUG3 trials

Sponsors

Pfizer, Pain Therapeutics, Ensysce Biosciences

Conditions

Healthy VolunteersManagement of Moderate to Severe PainOpioid Abuse Nondependent

Phase 1

Pharmacokinetics Study of ALO-02 and OxyContin

CompletedNCT01557257

PfizerManagement of Moderate to Severe Pain

Start: 2012-03-31End: 2012-05-31Updated: 2012-06-28

Nasal Human Abuse Potential of PTI-821

CompletedNCT03475862

Pain TherapeuticsOpioid Abuse Nondependent

Start: 2017-05-15End: 2017-12-15Updated: 2018-03-23

Evaluation of Oral PF614 Relative to OxyContin (PF614-102)

CompletedNCT05043766

Ensysce BiosciencesHealthy Volunteers

Start: 2021-09-08End: 2022-03-21Updated: 2024-09-24